Ryan J. Watts - Feb 9, 2022 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Feb 9, 2022
Transactions value $
$297,881
Form type
4
Date filed
2/11/2022, 04:19 PM
Previous filing
Jan 7, 2022
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$102K -2.72K -0.13% $37.55 2.12M Feb 9, 2022 See footnote F1, F2, F3, F4
transaction DNLI Common Stock Options Exercise $341K +64.6K +34.04% $5.28* 255K Feb 10, 2022 Direct
transaction DNLI Common Stock Options Exercise $58.7K +6.12K +2.4% $9.60 261K Feb 10, 2022 Direct F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNLI Stock Option (right to buy) Options Exercise $0 -64.6K -100% $0.00* 0 Feb 10, 2022 Common Stock 64.6K $5.28 Direct F6
transaction DNLI Stock Option (right to buy) Options Exercise $0 -6.12K -100% $0.00* 0 Feb 10, 2022 Common Stock 6.12K $9.60 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.
F2 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $37.51 to $37.745 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3 Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8800 restricted stock units held by the Reporting Person.
F4 The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
F5 Includes 189,891 restricted stock units.
F6 The shares subject to the option were fully vested and exercisable.